Yi Xue

461 citations
24 papers · 348 indexed · h-index 11
Topics
S100 Proteins and Annexins (5 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers)Occupational and environmental lung diseases (4 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Yi Xue

21 papers receiving 346 citations

Peers

Yi Xue
Comparison fields: 5 of 68
  • Molecular Biology 198
  • Pulmonary and Respiratory Medicine 117
  • Cancer Research 67
  • Immunology 55
  • Oncology 46
Replace Jiming Bao with:
Jiming Bao China
Zhaoyan Qiu China
Shamini G. Shekeran Singapore
Yu–Fu Su Taiwan
Lijin Zhao China
Isabelle Laverdière Canada
Kouhei Tsuchida Japan
Yu Zeng China
Yong Mou China
Yi Xue relative to Jiming Bao China Jiming Bao's profile →
Citations per field
00.5×1.5×2.2×
Jiming Bao · 1×
Citations per year

Countries citing papers authored by Yi Xue

Since Specialization
Citations

This map shows the geographic impact of Yi Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Xue more than expected).

Fields of papers citing papers by Yi Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Xue. The network helps show where Yi Xue may publish in the future.

Co-authorship network of co-authors of Yi Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Xue. A scholar is included among the top collaborators of Yi Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Xue. Yi Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 10
4 7
5 0
6 1
7 18
8 26
9 14
10 36
11 13
12 9
13 31
14 45
15 45
16 18
17 29
18
[Effect of coenzyme Q10 on the expression of tumor necrosis factor-α and interleukin-10 in gingival tissue of experimental periodontitis in rats].
7
19 18
20 9

About Yi Xue

Yi Xue is a scholar working on Molecular Biology, Immunology and Oncology, having authored 24 papers that have together received 348 indexed citations. Recurring topics across this work include S100 Proteins and Annexins (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Occupational and environmental lung diseases (4 papers). The work is most often cited by research in Cancer Research (67 citations), Pulmonary and Respiratory Medicine (117 citations) and Molecular Biology (198 citations). Yi Xue has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Weidong Zhu, Rihua Zhang, Yun Liu, Xuemin Gao, Hong Xu, Shifeng Li, Dingjie Xu, Wenchen Cai, Menglan Liu and Qiong Huang. Their work appears in journals such as Advanced Functional Materials, ACS Applied Materials & Interfaces and Experimental Cell Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026